Kerrii B. Anderson has served as a director of the Company since May 17, 2006. Ms. Anderson is the former Chief Executive Officer, President and Chief Financial Officer of Wendy’s International. Prior to joining Wendy’s in 2000, she was senior vice president and chief financial officer for 14 years for M/I Schottenstein Homes, Inc., a NYSE company that builds single-family homes.
Ms. Anderson has served as a director of Abercrombie & Fitch Co. since February 2018, The Sherwin-Williams Company since April 2019, and Worthington Industries, Inc. since September 2010. She was previously a director of the board of Chiquita Brands International from 2009 to 2012, and was chairwoman of the board from 2012 until the company’s acquisition in 2015. She was also a member of the board of P.F. Chang’s China Bistro from 2009 to 2012. Ms. Anderson also serves on the boards of the following non-profit entities: The Columbus Foundation, Ohio Health Board of Trustees and Elon University Board of Trustees.
Ms. Anderson has a strong record of leadership in operations, strategy, finance and talent management as a result of her experience at Wendy’s. Ms. Anderson also has significant expertise in the areas of accounting and financial reporting, corporate finance, corporate governance, and executive compensation through her service on other large public company boards. The breadth of experience enables Ms. Anderson to advise our Board on a variety of matters related to global operations and business strategy.
What is Kerrii B. Anderson's net worth?
The estimated net worth of Kerrii B. Anderson is at least $2.27 million as of July 24th, 2025. Ms. Anderson owns 8,666 shares of Labcorp stock worth more than $2,265,466 as of December 5th. This net worth approximation does not reflect any other investments that Ms. Anderson may own. Learn More about Kerrii B. Anderson's net worth.
How do I contact Kerrii B. Anderson?
Has Kerrii B. Anderson been buying or selling shares of Labcorp?
Kerrii B. Anderson has not been actively trading shares of Labcorp during the past quarter. Most recently, Kerrii B. Anderson sold 3,500 shares of the business's stock in a transaction on Thursday, July 24th. The shares were sold at an average price of $280.00, for a transaction totalling $980,000.00. Following the completion of the sale, the director now directly owns 8,666 shares of the company's stock, valued at $2,426,480. Learn More on Kerrii B. Anderson's trading history.
Who are Labcorp's active insiders?
Labcorp's insider roster includes Kerrii Anderson (Director), Jean-Luc Belingard (Director), Lance Berberian (EVP), Brian Caveney (EVP), Jonathan DiVincenzo (EVP and President, Central Laboratories and International), Glenn Eisenberg (CFO), Dwight Gilliland (Director), Paul Kirchgraber (CEO), Peter Neupert (Director), Richelle Parham (Director), Adam Schechter (Chairman, President, and CEO), Mark Schroeder (EVP), Amy Summy (CMO), Sandra van der Vaart (EVP), Peter Wilkinson (CAO), and R. Williams (Director). Learn More on Labcorp's active insiders.
Are insiders buying or selling shares of Labcorp?
During the last year, insiders at the medical research company sold shares 19 times. They sold a total of 54,892 shares worth more than $14,048,330.71. The most recent insider tranaction occured on November, 11th when CEO Adam H Schechter sold 5,745 shares worth more than $1,509,498.75. Insiders at Labcorp own 0.8% of the company.
Learn More about insider trades at Labcorp. Information on this page was last updated on 11/11/2025.
